Nectar Lifesciences Limited — Important, 28-11-2024: Updates

All Global Depositary Receipts (GDRs) associated with Nectar Lifesciences Ltd. have been cancelled and converted into equity shares. Consequently, there are no outstanding GDRs with Deutsche Bank Trust Company Americas, resulting in the delisting of GDRs from the Luxembourg Stock Exchange (LuxSE). This development may enhance the liquidity of the company's equity shares in the domestic market while reducing complexities associated with GDR operations. Investors should monitor the potential impacts on trading volume and overall market perception connected to this delisting.